# AbCellera Biologics Inc.: Form 8-K, filed Feb 21, 2023

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2023-02-21
- Accepted by EDGAR: Feb 21, 2023, 16:51 ET
- Period: 2023-02-21
- Accession: 0001564590-23-002126
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000156459023002126/abcl-8k_20230221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000156459023002126/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000156459023002126/abcl-8k_20230221.htm

Filed Feb 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001564590-23-002126. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
